-
Security Type
-
Common Stock
-
Categories
-
Healthcare & Medical
-
Min Investment
-
$500
-
Offering Date
-
July 29, 2021
-
Expected Close Date
-
March 18, 2022
-
Target Raise
-
$10.00K-$5.00M
-
No. Investors
-
164
-
Security Price
-
$5
-
Valuation
-
$50,000,000
- Number of Employees
- 10
- Cash
- $0
- Revenue
- $0
- Short Term Debt
- $0
- Cost of Goods
- $0
- Long Term Debt
- $0
- Net Income
- $0
Company Description
Psilothera is a pioneering mental health care company dedicated to creative, modern solutions to treat global healthcare concerns, including depression, anxiety, PTSD, eating disorders, addictions, Alzheimer’s, dementia, and more. We plan to deploy quantum technology to shorten the drug development time, which will give us an advantage over our competitors. With a focus on healing, hope, and compassion, we aim to change the paradigm of mental healthcare with their Psilocybin-based therapies.
Perks
StartEngine OWNERS Exclusive Click here to learn more
$500+ Investment
StartEngine Owner’s Bonus
This offering is eligible for the StartEngine Owner’s 10% Bonus program. For details on this program, please see the Offering Summary section below.
$50,000+ Investment
Tier 1: $50,000+ Invest $50,000 or more and receive 5% bonus shares
$75,000+ Investment
Tier 2: $75,000+ Invest $75,000 or more and receive 7% bonus shares
$100,000+ Investment
Tier 3: $100,000+ Invest $100,000 or more and receive 10% bonus shares
Key Deal Facts
Psilothera is stepping into the scene of major healthcare crisis by focusing on medical research breakthroughs and groundbreaking legalizations
The company is actively targeting a $100 billion market opportunity in Psilocybin healthcare
Psilothera is led by a battle tested management team with business model, strategy and plan driven by research and development